{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:58:29Z","timestamp":1792519109862,"version":"4.5.0"},"reference-count":144,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.autrev.2013.10.010","type":"journal-article","created":{"date-parts":[[2013,11,2]],"date-time":"2013-11-02T00:46:08Z","timestamp":1383353168000},"page":"272-280","source":"Crossref","is-referenced-by-count":540,"title":["Chemokine (C\u2013X\u2013C motif) ligand (CXCL)10 in autoimmune diseases"],"prefix":"10.1016","volume":"13","author":[{"given":"Alessandro","family":"Antonelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Martina","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilia","family":"Giuggioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ele","family":"Ferrannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clodoveo","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poupak","family":"Fallahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2013.10.010_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.68.1.1","article-title":"CXC chemokines in angiogenesis","volume":"68","author":"Belperio","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0010","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.2174\/092986710793176366","article-title":"Anticancer properties of the IL-12 family\u2014focus on colorectal cancer","volume":"17","author":"Engel","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.autrev.2013.10.010_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.autrev.2008.07.017","article-title":"Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia","volume":"8","author":"Antonelli","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2008.12.002","article-title":"CXCL10 and autoimmune diseases","volume":"8","author":"Lee","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.autrev.2012.05.003","article-title":"What is the key environmental trigger in type 1 diabetes\u2014is it viruses, or wheat gluten, or both?","volume":"12","author":"Barbeau","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0030","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.autrev.2012.12.004","article-title":"Is autoimmune diabetes caused by aberrant immune activity or defective suppression of physiological self-reactivity?","volume":"12","author":"Askenasy","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.autrev.2005.12.001","article-title":"Dendritic cell subsets and type I diabetes: focus upon DC-based therapy","volume":"5","author":"Lo","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.24.3.510","article-title":"Elevated serum IP-10 levels observed in type 1 diabetes","volume":"24","author":"Shimada","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autrev.2013.10.010_bb0045","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00125-002-0879-5","article-title":"Serum concentrations of the interferon-gamma-inducible chemokine IP-10\/CXCL10 are augmented in both newly diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease","volume":"45","author":"Nicoletti","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.autrev.2013.10.010_bb0050","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1196\/annals.1288.059","article-title":"Two cases of \u201cfulminant\u201d type 1 diabetes suggesting involvement of autoimmunity","volume":"1005","author":"Nakagawa","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.10.010_bb0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2249.2011.04538.x","article-title":"Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients","volume":"168","author":"Gabbay","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.10.010_rf0660","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00125-002-0879-5","article-title":"Serum concentrations of the interferon-alpha-inducible chemokine IP-10\/CXCL10 are augmented in both newly-diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease","volume":"45","author":"Rotondi","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.autrev.2013.10.010_rf0665","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00125-003-1134-4","volume":"46","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.autrev.2013.10.010_bb0065","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1464-5491.2005.01743.x","article-title":"Altered chemokine levels in individuals at risk of type 1 diabetes mellitus","volume":"23","author":"Hanifi-Moghaddam","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.autrev.2013.10.010_bb0070","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1464-5491.2008.02577.x","article-title":"Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study","volume":"25","author":"Antonelli","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.autrev.2013.10.010_bb0075","doi-asserted-by":"crossref","first-page":"31212","DOI":"10.1074\/jbc.M602445200","article-title":"Interferon-gamma-inducible protein (IP)-10 mRNA stabilized by RNA-binding proteins in monocytes treated with S100b","volume":"281","author":"Shanmugam","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2013.10.010_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/dmrr.1052","article-title":"Ex vivo TCR-induced leukocyte gene expression of inflammatory mediators is increased in type 1 diabetic patients but not in overweight children","volume":"26","author":"Rosa","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0085","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm1202-792","article-title":"Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis","volume":"8","author":"Frigerio","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2013.10.010_bb0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2249.2009.04087.x","article-title":"Islet inflammation and CXCL10 in recent-onset type 1 diabetes","volume":"159","author":"Roep","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0095","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1507\/endocrj.K10E-076","article-title":"Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes","volume":"57","author":"Uno","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.autrev.2013.10.010_bb0100","doi-asserted-by":"crossref","first-page":"8401","DOI":"10.4049\/jimmunol.175.12.8401","article-title":"CXCL10 DNA vaccination prevents spontaneous diabetes through enhanced beta cell proliferation in NOD mice","volume":"175","author":"Shigihara","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.autrev.2008.07.013","article-title":"Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology","volume":"8","author":"Tozzoli","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.autrev.2008.04.006","article-title":"Autoimmune thyroiditis and ROS","volume":"7","author":"Burek","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0710","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1210\/jcem.86.10.7953","article-title":"Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes","volume":"86","author":"Garci\u00e0-L\u00f2pez","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2013.10.010_bb0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2265.2003.01824.x","article-title":"Detection and localization of chemokine gene expression in autoimmune thyroid disease","volume":"59","author":"Kemp","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yexmp.2004.08.004","article-title":"Early chemokine expression induced by interferon-gamma in a murine model of Hashimoto's thyroiditis","volume":"77","author":"Kimura","year":"2004","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0125","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1210\/jc.2004-0977","article-title":"High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism","volume":"89","author":"Antonelli","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2013.10.010_bb0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/eje.1.01847","article-title":"Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis","volume":"152","author":"Antonelli","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cyto.2008.01.002","article-title":"High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis","volume":"42","author":"Antonelli","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2013.10.010_bb0140","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.metabol.2008.04.023","article-title":"Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis","volume":"57","author":"Antonelli","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.autrev.2013.10.010_bb0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jir.2008.0090","article-title":"CXCL10 and CCL2 chemokine serum levels in patients with hepatitis C associated with autoimmune thyroiditis","volume":"29","author":"Antonelli","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.autrev.2013.10.010_bb0150","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/08916930802170401","article-title":"High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis","volume":"41","author":"Antonelli","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.10.010_bb0155","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1111\/j.1572-0241.2008.02040.x","article-title":"High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection","volume":"103","author":"Antonelli","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0160","first-page":"1809","article-title":"Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis","volume":"35","author":"Antonelli","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0165","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/jir.2010.0024","article-title":"Interleukin-1\u03b2, C\u2013X\u2013C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis","volume":"30","author":"Antonelli","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.autrev.2013.10.010_bb0170","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ncpendmet1027","article-title":"Endocrine manifestations of hepatitis C virus infection","volume":"5","author":"Antonelli","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.autrev.2013.10.010_bb0175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/eje.1.02137","article-title":"Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process","volume":"154","author":"Antonelli","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0180","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cyto.2011.04.022","article-title":"Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10","volume":"55","author":"Antonelli","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2013.10.010_bb0185","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/s10165-011-0565-x","article-title":"Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis","volume":"22","author":"Antonelli","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/jir.2011.0051","article-title":"High levels of circulating chemokine (C\u2013X\u2013C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C\u2013X\u2013C motif) ligand 10","volume":"32","author":"Antonelli","year":"2012","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.autrev.2013.10.010_bb0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0200","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/jc.2005-1689","article-title":"Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"91","author":"Antonelli","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2013.10.010_bb0205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/jc.2012-2555","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?","volume":"98","author":"Rotondi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2013.10.010_bb0210","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1210\/jc.2008-2450","article-title":"Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"94","author":"Antonelli","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2013.10.010_bb0215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.autrev.2010.08.018","article-title":"Bioassays for TSH-receptor autoantibodies: an update","volume":"10","author":"Lytton","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.autrev.2012.07.003","article-title":"TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis","volume":"12","author":"Tozzoli","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0029-1211053","article-title":"The autoimmune infiltrate of Basedow's disease: analysis of clonal level and comparison with Hashimoto's thyroiditis","volume":"97","author":"Mariotti","year":"1991","journal-title":"Exp Clin Endocrinol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0002-9440(10)64171-5","article-title":"Expression of IP-10\/CXCL10 and MIG\/CXCL9 in the thyroid and increased levels of IP-10\/CXCL10 in the serum of patients with recent-onset Graves' disease","volume":"161","author":"Romagnani","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0235","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2006.02447.x","article-title":"Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy","volume":"64","author":"Antonelli","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0240","first-page":"2873","article-title":"A one-tube polymerase chain reaction protocol demonstrates CC chemokine overexpression in Graves' disease glands","volume":"84","author":"Ashhab","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2013.10.010_bb0245","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/eje.0.1500225","article-title":"The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases","volume":"150","author":"Aust","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0250","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0002-9440(10)61762-2","article-title":"Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers","volume":"159","author":"Armengol","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0255","first-page":"435","article-title":"Serum cytokines in thyrotoxicosis","volume":"84","author":"Siddiqi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2013.10.010_bb0260","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-2008-1073151","article-title":"Circulating chemokines in patients with autoimmune thyroid diseases","volume":"40","author":"Domberg","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2013.10.010_bb0265","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0019","volume":"156","author":"Inukai","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0270","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1677\/JOE-07-0240","article-title":"Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes","volume":"195","author":"Crescioli","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0275","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/thy.2009.0222","article-title":"A CXC motif ligand 10 polymorphism as a marker to predict severity of Graves' disease","volume":"20","author":"Br\u00fcck","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2013.10.010_bb0280","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/thy.2009.0179","article-title":"Serum chemokine (C\u2013X\u2013C motif) ligand 10 levels are elevated in patients with Graves' disease in long-term remission","volume":"20","author":"Sakai","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2013.10.010_bb0285","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/bjs.5401","article-title":"Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy","volume":"93","author":"Antonelli","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.autrev.2013.10.010_bb0290","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1210\/jc.2006-1571","article-title":"Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter","volume":"92","author":"Antonelli","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2013.10.010_bb0295","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0031-1271620","article-title":"Influence of methimazole and radioactive iodine treatment in the serum levels of the chemokine CXCL10 in hyperthyroid patients with Graves' disease","volume":"43","author":"Leite","year":"2011","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2013.10.010_bb0300","doi-asserted-by":"crossref","first-page":"E262","DOI":"10.25011\/cim.v34i5.15668","article-title":"Short-term effect of radioactive iodine therapy on CXCL-10 production in Graves' disease","volume":"34","author":"Dong","year":"2011","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.autrev.2013.10.010_bb0305","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1055\/s-0032-1316352","article-title":"Circulating CXCL9 and CXCL10 as markers of activity of Graves' orbitopathy during treatment with corticosteroids and teleradiotherapy","volume":"44","author":"Mysliwiec","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2013.10.010_bb0310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1044-5323(02)00128-8","article-title":"Strategies for chemokine antagonists as therapeutics","volume":"15","author":"Proudfoot","year":"2003","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0315","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.4049\/jimmunol.164.12.6503","article-title":"Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells","volume":"164","author":"Marx","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0320","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X","article-title":"Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells","volume":"31","author":"Gosset","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0325","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.MIB.0000160770.94199.9b","article-title":"Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms","volume":"11","author":"Schaefer","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.10.010_bb0330","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.metabol.2010.02.002","article-title":"Cytokines (interferon-\u03b3 and tumor necrosis factor-\u03b1)-induced nuclear factor-\u03baB activation and chemokine (C\u2013X\u2013C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone","volume":"60","author":"Antonelli","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.autrev.2013.10.010_bb0335","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/intimm\/9.10.1581","article-title":"Constitutive activation of NF-kappa B in an animal model of aging","volume":"9","author":"Spencer","year":"1997","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0340","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejphar.2006.12.026","article-title":"Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma","volume":"561","author":"Oliveira","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0345","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2007.03.113","article-title":"Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10 deficient mice","volume":"133","author":"Lee","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.10.010_bb0350","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.yexcr.2011.04.007","article-title":"Peroxisome proliferator-activated receptor \u03b1 agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease","volume":"317","author":"Antonelli","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.autrev.2013.10.010_bb0355","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1","volume":"274","author":"Delerive","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2013.10.010_bb0360","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nature03988","article-title":"A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma","volume":"437","author":"Pascual","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2013.10.010_bb0365","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/rheumatology\/38.11.1058","article-title":"The elevated ratio of interferon gamma-\/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta","volume":"38","author":"Yin","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2013.10.010_bb0370","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.autrev.2012.10.001","article-title":"The interaction between CXCL10 and cytokines in chronic inflammatory arthritis","volume":"12","author":"Lee","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0375","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/ar616","article-title":"A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis","volume":"5","author":"Hanaoka","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2013.10.010_bb0380","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.23372","article-title":"Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis","volume":"58","author":"Kwak","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.10.010_bb0385","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B","article-title":"Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis","volume":"43","author":"Wedderburn","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.10.010_bb0390","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1002\/1529-0131(200112)44:12<2750::AID-ART462>3.0.CO;2-C","article-title":"Selective lymphocyte chemokine receptor expression in the rheumatoid joint","volume":"44","author":"Ruth","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.10.010_bb0395","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/art.34330","article-title":"A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis","volume":"64","author":"Yellin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.10.010_bb0400","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.1993.tb03360.x","article-title":"Synovial fluid cells in juvenile arthritis: evidence of selective T cell migration to inflamed tissue","volume":"91","author":"Silverman","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0405","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar1913","article-title":"Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells","volume":"8","author":"Pharoah","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2013.10.010_bb0410","first-page":"22","article-title":"High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthritis","volume":"27","author":"Antonelli","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0415","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/ard.2006.054924","article-title":"Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines","volume":"66","author":"Hueber","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2013.10.010_bb0420","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/030097498440859","article-title":"Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus","volume":"27","author":"Funauchi","year":"1998","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0425","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0161-5890(95)00024-9","article-title":"Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-10 and interferon gamma mRNA in the lymph nodes of lupus-prone mice","volume":"32","author":"Prud'homme","year":"1995","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0430","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S","article-title":"Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation","volume":"194","author":"Flier","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0435","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.1721","article-title":"Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus","volume":"205","author":"Wenzel","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0440","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.21034","article-title":"Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus","volume":"52","author":"Meller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.10.010_bb0445","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1684\/ejd.2012.1725","article-title":"Cytokine and chemokine ligand expression in cutaneous lupus erythematosus","volume":"22","author":"Gambichler","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0450","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1006\/cyto.2000.0757","article-title":"Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus","volume":"12","author":"Narumi","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2013.10.010_bb0455","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/ard.2005.038315","article-title":"Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus","volume":"65","author":"Lit","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2013.10.010_bb0460","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.autrev.2013.07.004","article-title":"Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features","volume":"12","author":"Toledano","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0465","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.autrev.2012.08.014","article-title":"Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria","volume":"12","author":"Sciascia","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0470","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","article-title":"Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus","volume":"56","author":"Fragoso-Loyo","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.10.010_bb0475","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.58.8.1214","article-title":"Neuropsychiatric syndromes in lupus: prevalence using standardized definitions","volume":"58","author":"Brey","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.10.010_bb0480","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12016-010-8197-z","article-title":"Urinary biomarkers in lupus nephritis","volume":"40","author":"Reyes-Thomas","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0485","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1186\/ar3363","article-title":"Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2013.10.010_bb0490","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.autrev.2013.06.013","article-title":"Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature","volume":"12","author":"Giuggioli","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0495","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002281-200001000-00009","article-title":"Relation between infection and autoimmunity in mixed cryoglobulinemia","volume":"12","author":"Ferri","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0500","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-137-7-200210010-00008","article-title":"Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas","volume":"137","author":"Zignego","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2013.10.010_bb0505","series-title":"Infectious causes of cancer. Targets for intervention","first-page":"349","article-title":"Hepatitis C virus infection and in non-Hodgkin's lymphoma","author":"Ferri","year":"2000"},{"key":"10.1016\/j.autrev.2013.10.010_bb0510","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood-2002-05-1537","article-title":"Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation","volume":"102","author":"Giannelli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.10.010_bb0515","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jhep.2004.08.011","article-title":"Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis","volume":"41","author":"Saadoun","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0520","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0168-8278(02)00353-7","article-title":"Enhanced monocyte Th1 cytokine production in HCV-infected cryoglobulinemic patients","volume":"38","author":"Loffreda","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0715","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1128\/JVI.75.3.1332-1338.2001","article-title":"Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization","volume":"75","author":"Patzwahl","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0525","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jmv.10431","article-title":"Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B","volume":"70","author":"Mihm","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0530","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/sj.gt.3302091","article-title":"Exploiting hepatitis C virus activation of NFkappaB to deliver HCV-responsive expression of interferons alpha and gamma","volume":"10","author":"Matskevich","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.autrev.2013.10.010_bb0535","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jmv.2205","article-title":"Increased frequency of IFN-gamma-producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C","volume":"67","author":"Murata","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0540","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2893.2001.00309.x","article-title":"Clinical significance of elevated serum interferon- inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels","volume":"8","author":"Itoh","year":"2001","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.autrev.2013.10.010_bb0545","first-page":"S39","article-title":"HCV infection: pathogenesis, clinical manifestations and therapy","volume":"26","author":"Antonelli","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0550","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrgastro.2009.168","article-title":"Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy","volume":"6","author":"Antonelli","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0555","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2893.2005.00540.x","article-title":"Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins","volume":"12","author":"Apolinario","year":"2005","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.autrev.2013.10.010_bb0560","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3899\/jrheum.110133","article-title":"High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-\u03b3","volume":"38","author":"Antonelli","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0565","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3899\/jrheum.090246","article-title":"Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection","volume":"37","author":"Antonelli","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0570","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.dld.2008.04.009","article-title":"CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C","volume":"41","author":"Antonelli","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2013.10.010_bb0575","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002689900132","article-title":"Epidemiologic and clinical evaluation of thyroid cancer in children from the Gomel region (Belarus)","volume":"20","author":"Antonelli","year":"1996","journal-title":"World J Surg"},{"key":"10.1016\/j.autrev.2013.10.010_bb0580","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jpedsurg.2004.06.016","article-title":"Surgical therapy of the thyroid papillary carcinoma in children: experience with 56 patients<or=16years old","volume":"39","author":"Spinelli","year":"2004","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.autrev.2013.10.010_bb0585","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1001\/jama.281.17.1588","article-title":"Thyroid cancer in patients with hepatitis C infection","volume":"281","author":"Antonelli","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2013.10.010_bb0590","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/1097-0215(20000815)87:4<611::AID-IJC24>3.0.CO;2-N","article-title":"Is hepatitis C virus infection associated with thyroid cancer? A case\u2013control study","volume":"87","author":"Montella","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.autrev.2013.10.010_bb0595","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1034\/j.1600-0676.2001.210506.x","article-title":"HCV and cancer: a case\u2013control study in a high-endemic area","volume":"21","author":"Montella","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.autrev.2013.10.010_bb0600","first-page":"693","article-title":"Thyroid cancer in HCV-related mixed cryoglobulinemia patients","volume":"20","author":"Antonelli","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0605","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/ERC-11-0028","article-title":"Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine","volume":"18","author":"Fiore","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.autrev.2013.10.010_bb0610","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/thy.2006.0194","article-title":"Thyroid cancer in HCV-related chronic hepatitis patients: a case\u2013control study","volume":"17","author":"Antonelli","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2013.10.010_bb0615","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1590-8658(07)80005-3","article-title":"HCV-related autoimmune and neoplastic disorders: the HCV syndrome","volume":"39","author":"Ferri","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2013.10.010_bb0620","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/oem.51.4.239","article-title":"Findings from high resolution computed tomography of the lung and pleura of symptom free workers exposed to amosite who had normal chest radiographs and pulmonary function tests","volume":"51","author":"Neri","year":"1994","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.autrev.2013.10.010_bb0625","doi-asserted-by":"crossref","first-page":"E288","DOI":"10.1210\/jc.2010-1905","article-title":"Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer","volume":"96","author":"Antonelli","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2013.10.010_bb0630","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.biopha.2008.07.056","article-title":"Dedifferentiated thyroid cancer: a therapeutic challenge","volume":"62","author":"Antonelli","year":"2008","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.autrev.2013.10.010_bb0635","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI200522758","article-title":"The RET\/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells","volume":"115","author":"Melillo","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.10.010_bb0640","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1677\/erc.1.00947","article-title":"RET\/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response","volume":"12","author":"Puxeddu","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.autrev.2013.10.010_bb0645","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1677\/ERC-08-0337","article-title":"Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"16","author":"Antonelli","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.autrev.2013.10.010_bb0650","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2010.05.004","article-title":"Immunological profile in primary Sj\u00f6gren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease","volume":"9","author":"Fauchais","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0655","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/art.21745","article-title":"Antagonist of interferon-inducible protein 10\/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL\/lpr mice","volume":"54","author":"Hasegawa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.10.010_bb0660","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.autrev.2013.05.002","article-title":"Systemic sclerosis at the crossroad of polyautoimmunity","volume":"12","author":"Elhai","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.10.010_bb0665","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jdermsci.2004.03.001","article-title":"Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis","volume":"35","author":"Fujii","year":"2004","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2013.10.010_bb0670","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/kem313","article-title":"CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis\u2014a longitudinal study","volume":"47","author":"Antonelli","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2013.10.010_bb0675","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.revmed.2009.05.001","article-title":"Increase of CXCL10 serum level in systemic sclerosis interstitial pneumonia","volume":"30","author":"Tiev","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2013.10.010_bb0680","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10067-010-1610-4","article-title":"Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis","volume":"30","author":"Hasegawa","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0685","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3899\/jrheum.111132","article-title":"Systemic sclerosis fibroblasts show specific alterations of interferon-\u03b3 and tumor necrosis factor-\u03b1-induced modulation of interleukin 6 and chemokine ligand 2","volume":"39","author":"Antonelli","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0690","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/ar3242","article-title":"Dysregulated expression of MIG\/CXCL9, IP-10\/CXCL10 and CXCL16 and their receptors in systemic sclerosis","volume":"13","author":"Rabquer","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2013.10.010_bb0695","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2133.2010.09844.x","article-title":"Induction of CXCL10 secretion by interferon-\u03b3 and tumour necrosis factor-\u03b1 and its inhibition by peroxisome proliferator-activated receptor-\u03b3 agonists in cultured scleroderma fibroblasts","volume":"163","author":"Antonelli","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0700","article-title":"Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study","author":"Hasegawa","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2013.10.010_bb0705","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.37742","article-title":"Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis","volume":"65","author":"Liu","year":"2013","journal-title":"Arthritis Rheum"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213002036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213002036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T01:56:53Z","timestamp":1716083813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213002036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1568997213002036"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.10.010","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}